Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
USA 116 , 26722680 (2019)
doi: 10.1136/annrheumdis-2014-206106 43 SchaferPHKivitzAJMaJKorishSSutherlandDLiLet al
Recent advances in clinical trials of glutamine metabolism inhibitors In the landscape of oncological research, the inhibition of glutamine metabolism has emerged from preclinical studies as a compelling avenue for therapeutic intervention, sparking fervent interest in its clinical application
Vigorously shaking a reconstituted peptide can damage the delicate amino acid chains, potentially rendering it less effective or completely inert
More open chromatin (from acetylation) increases gene accessibility for transcription
US$ 25.64
US$ 21.17
US$ 24.68
